FAST TRACK AHEAD OF PRINT
COVID-19 VACCINE DEVELOPMENT MODELS
Today Health Affairs is releasing a cluster of three Fast Track Ahead Of Print analyses, examining factors contributing to the successful accelerated development of COVID-19 vaccines, and how some of the lessons learned could be applied to future research and distribution. The analyses also address aspects of vaccine distribution and the challenges of addressing public concerns related to the vaccines.
How New Models Of Vaccine Development For COVID-19 Have Helped Address An Epic Public Health Crisis
By David E. Bloom, Daniel Cadarette, Maddalena Ferranna, Randall N. Hyer, and Daniel L. Tortorice
Reflections On Governance, Communication, And Equity: Challenges And Opportunities In COVID-19 Vaccination
By Daniel Salmon, Douglas J. Opel, Matthew Z. Dudley, Janesse Brewer, and Robert Breiman
The COVID-19 Innovation System
By Bhaven N. Sampat and Kenneth C. Shadlen
Health Affairs’ cluster of articles focused on COVID-19 vaccines and therapeutics was supported by Alexion, Amgen Inc., Anthem, Inc., Avalere Health, Beckman Coulter, Dynavax Technologies Corporation, Gilead, Kaiser Permanente, McKesson, Pharmaceutical Research and Manufacturers of America (PhRMA), and Quest Diagnostics.
|
